In today’s rapidly advancing medical technology landscape, the proposal and practice of integrated imaging not only marks the integration and further development of medical imaging disciplines, but also represents an indispensable cornerstone in the era of precision medicine. As a national key (nurturing) discipline, the Department of Imaging and Nuclear Medicine at China Medical University has always been at the forefront of scientific innovation, dedicated to driving the thorough implementation and broad application of the integrated imaging concept.
Chapter 1 Overview of Gynecological Malignancies 1
1.1. Overview of Cervical Cancer 1
1.2. Overview of Endometrial Carcinoma 7
1.3. Overview of Ovarian Cancer 14
1.4. Overview of Other Rare Gynecological Malignancies 21
References 27
Chapter 2 Introduction to PET/CT and PET/MR Technology 28
2.1. Historical Development of PET Technology 28
2.2. PET/CT Imaging 33
2.3. PET/MR Imaging 40
References 46
Chapter 3 Normal Anatomy of the Female Reproductive System and Its CT/MR/PET Appearances 47
3.1. Normal Anatomy of the Female Reproductive System 47
3.2. Normal CT Appearances of the Female Reproductive System 47
3.3. Normal MR Appearances of the Female Reproductive System 48
3.4. Normal PET Appearances of the Female Reproductive System 50
Chapter 4 Comparative Case-Control Analysis of PET/CT and PET/MR in Cervical Cancer 52
4.1. Case 1: Cervical Cancer, FIGO Stage ⅠB1 53
4.2. Case 2: Cervical Cancer, FIGO Stage ⅡA2 57
4.3. Case 3: Cervical Cancer, FIGO Stage ⅡB 60
4.4. Case 4: Cervical Cancer, FIGO Stage ⅢA 62
4.5. Case 5: Cervical Cancer, FIGO Stage ⅢB 66
4.6. Case 6: Cervical Cancer, FIGO Stage ⅢC 69
4.7. Case 7: Cervical Cancer, FIGO Stage ⅣB 73
4.8. Case 8: Therapeutic Response Assessment in a Cervical Cancer Patient 78
References 80
Chapter 5 Comparative Case-Control Analysis of PET/CT and PET/MR in Endometrial Carcinoma 81
5.1. Case 1: Endometrial Carcinoma, FIGO Stage ⅠA 82
5.2. Case 2: Endometrial Carcinoma, FIGO Stage ⅠB 86
5.3. Case 3: Endometrial Carcinoma, FIGO Stage ⅡA 90
5.4. Case 4: Endometrial Carcinoma, FIGO Stage ⅢC 95
5.5. Case 5: Endometrial Carcinoma, FIGO Stage ⅣC 100
5.6. Case 6: Lynch Syndrome 104
References 110
Chapter 6 Comparative Case-Control Analysis of PET/CT and PET/MR in Ovarian Cancer 111
6.1. Case 1: Ovarian Cancer, FIGO Stage ⅠC2 112
6.2. Case 2: Ovarian Cancer, FIGO Stage ⅡB 116
6.3. Case 3: Ovarian Cancer, FIGO Stage ⅢB 120
6.4. Case 4: Ovarian Metastatic Cancer 125
References 129
Chapter 7 Comparative Case-Control Analysis of PET/CT and PET/MR in Other Rare Gynecological Malignancies 131
7.1. Case 1: Uterine Carcinosarcoma, FIGO Stage ⅠA 132
7.2. Case 2: Vaginal Cancer, FIGO Stage Ⅰ 137
References 140
Chapter 8 Current Applications and Prospects of PET/CT and PET/MR in Gynecological Malignancies 142
8.1. Current Applications 142
8.2. Prospects 143
Index of English Abbreviations 145
